港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

来凯医药-B

16.480

-0.180-1.08%

成交量：180.70万

成交额：3,063.01万

市值：67.24亿

市盈率：-21.24

高：17.390

开：17.000

低：16.470

收：16.660

52周最高：23.500

52周最低：4.200

股本：4.08亿

香港流通股本：4.08亿

量比：1.03

换手率：0.44%

股息：- -

股息率：- -

每股收益(LYR):-0.776

净资产收益率：-34.59%

总资产收益率：-19.92%

市净率：8.64

市盈率(LYR):-21.24

市销率: 1331.61

数据加载中...

总览公司新闻公告

来凯医药-B(02105)上半年核心管线临床进展显著研发费用逾1亿元

来凯医药-B08月12日遭主力抛售186.1万元

每日卖空追踪 | 来凯医药-B 08月11日卖空量成交4.5万股，卖空比例为2.29%

下周备忘

阿斯达克财经

每日卖空追踪 | 来凯医药-B 08月08日卖空量成交5.6万股，卖空比例为5.39%

来凯医药-B08月07日主力净流出42.4万元散户资金买入

每日卖空追踪 | 来凯医药-B 08月06日卖空量成交3.8万股，卖空比例为1.5%

来凯医药-B08月06日主力净流入201.3万元散户资金抛售

每日卖空追踪 | 来凯医药-B 08月04日卖空量成交4.6万股，卖空比例为2.3%

来凯医药-B盘中异动下午盘股价大涨5.02%

中金：首予来凯医药-B(02105)跑赢行业评级目标价27.02港元

这款中国创新药管线，诺和诺德最应该BD

每日卖空追踪 | 来凯医药-B 08月01日卖空量成交9500股，卖空比例为0.3%

来凯医药-B盘中异动早盘股价大跌5.32%报17.800港元

来凯医药-B：减脂增肌赛道新锐全球化创新布局

来凯医药-B(02105.HK)：LAE103的新药临床试验已获得美国食品药品监督管理局批准

来凯医药-B：LAE103的新药临床试验(IND)已获得美国FDA批准

每日卖空追踪 | 来凯医药-B 07月30日卖空量成交1000股，卖空比例为0.03%

来凯医药-B拟8月13日举行董事会会议批准中期业绩

来凯医药-B07月29日获主力加仓1600.4万元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02105/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":16.48,"timestamp":1756186916741,"preClose":16.66,"halted":0,"volume":1807000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.775977902410457,"marketStatus":"交易中","change":-0.18,"latestTime":"08-26 13:42:07","open":17,"high":17.39,"low":16.47,"amount":30630087,"amplitude":0.055222,"askPrice":16.49,"askSize":2000,"bidPrice":16.48,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.7136839007238399,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":16.66,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":1.028744,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.775978,"volumeRatio":1.028744,"shares":408000000,"dividePrice":0,"high":17.39,"amplitude":0.055222,"preClose":16.66,"low":16.47,"week52Low":4.2,"pbRate":"8.64","psRate":"1331.61","week52High":23.5,"institutionHeld":0,"latestPrice":16.48,"committee":0.2,"eps":-0.775977902410457,"divideRate":0,"volume":1807000,"delay":0,"ttmEps":-0.7136839007238399,"open":17,"prevYearClose":9.37,"prevWeekClose":17.19,"prevMonthClose":18.8,"prevQuarterClose":17.46,"fiveDayClose":17.98,"twentyDayClose":19.98,"sixtyDayClose":19.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盘后","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754496000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-08-25","current":-24.093478,"percent":0.08818,"low":-30.832985,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"high":-1.640852,"avg":-10.791117,"sd":7.187702,"marketCap":6322695243},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-25","current":-24.093478,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"marketCap":6322695243}],"updateTime":1756186927627},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559603452","title":"来凯医药-B(02105)上半年核心管线临床进展显著 研发费用逾1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559603452","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559603452?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 17:19","pubTimestamp":1755076776,"startTime":"0","endTime":"0","summary":"智通财经APP讯，来凯医药-B 发布截至2025年6月30日止6个月的中期业绩，该集团取得其他收入人民币1990.8万元，同比增加40.7%;研发费用1.05亿元，同比减少16.61%;期内亏损1.3亿元，同比减少9.79%。研发费用减少主要是由于2024年上半年产生与III期临床试验AFFIRM-205有关的里程碑付款人民币1780万元，而于报告期内并无产生该类费用。2024年5月，集团已获FDA批准此III期临床试验的方案。集团计划于2025年下半年启动LAE103的I期临床研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161"],"gpt_icon":1},{"id":"2558610997","title":"来凯医药-B08月12日遭主力抛售186.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558610997","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558610997?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 16:15","pubTimestamp":1754986512,"startTime":"0","endTime":"0","summary":"08月12日, 来凯医药-B股价跌2.00%，报收18.62元，成交金额2856.3万元，换手率0.37%，振幅7.21%，量比0.74。来凯医药-B今日主力资金净流出186.1万元，上一交易日主力净流出124.6万元。该股近5个交易日下跌4.62%，主力资金累计净流出80.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入3967.3万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812165523a483b8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812165523a483b8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2558652356","title":"每日卖空追踪 | 来凯医药-B 08月11日卖空量成交4.5万股，卖空比例为2.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558652356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558652356?lang=zh_cn&edition=fundamental","pubTime":"2025-08-11 16:30","pubTimestamp":1754901028,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间08月11日，涨1.6%，卖空量成交4.5万股%，较上一交易日减少55.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811171634a481ad16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811171634a481ad16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2557526886","title":"下周备忘","url":"https://stock-news.laohu8.com/highlight/detail?id=2557526886","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557526886?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 18:31","pubTimestamp":1754649060,"startTime":"0","endTime":"0","summary":"8月11日(周一)日本、泰国假期休市意大利7月调和CPI年率终值：预测升1.7%；初值升1.8%意大利7月调和CPI月率终值：预测跌1%；初值跌1%意大利7月CPI年率终值：初值升1.7%意大利7月CPI年率终值：初值升0.4%意大利6月贸易账：前值顺差61.63亿欧元业绩公布：康师傅(00322.HK)、金蝶(00268.HK)、阳光房地产基金(00435.HK)、丘钛(01478.HK)、博雅","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126150905143_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126150905143_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1459741/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00322","02878","00175","09618","00992","01113","00762","02586","09898","00435","01313","00127","02386","03939","02419","01349","09999","01698","00405","00999","01361","00978","00806","01857","00006","03813","00728","01083","01878","02616","00874","01548","00551","00066","00288","00808","01672","01928","02191","09985","09899","01910","06618","02105","01883","01378","01875"],"gpt_icon":1},{"id":"2557529504","title":"每日卖空追踪 | 来凯医药-B 08月08日卖空量成交5.6万股，卖空比例为5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557529504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557529504?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 16:30","pubTimestamp":1754641826,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间08月08日，跌1.06%，卖空量成交5.6万股%，较上一交易日减少58.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808175954a6dacc8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808175954a6dacc8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2557559312","title":"来凯医药-B08月07日主力净流出42.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2557559312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557559312?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 16:15","pubTimestamp":1754554558,"startTime":"0","endTime":"0","summary":"08月07日, 来凯医药-B股价跌5.26%，报收18.90元，成交金额3293.7万元，换手率0.42%，振幅6.57%，量比0.61。来凯医药-B今日主力资金净流出42.4万元，上一交易日主力净流入201.3万元。该股近5个交易日上涨0.48%，主力资金累计净流出143.5万元；近20日主力资金累计净流入3967.1万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807172241a47a9b08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807172241a47a9b08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2557348376","title":"每日卖空追踪 | 来凯医药-B 08月06日卖空量成交3.8万股，卖空比例为1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557348376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557348376?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 16:30","pubTimestamp":1754469027,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间08月06日，涨2.31%，卖空量成交3.8万股%，较上一交易日增加4.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806172806a6d6463e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806172806a6d6463e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2557379957","title":"来凯医药-B08月06日主力净流入201.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2557379957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557379957?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 16:15","pubTimestamp":1754468127,"startTime":"0","endTime":"0","summary":"08月06日, 来凯医药-B股价涨2.31%，报收19.95元，成交金额5011.3万元，换手率0.62%，振幅6.10%，量比0.82。来凯医药-B今日主力资金净流入201.3万元，上一交易日主力净流出139.1万元。该股近5个交易日上涨4.18%，主力资金累计净流入62.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入5007.2万元，其中净流入天数为15日。该股主力净额占比0.02%，港股市场排名239/2671。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170134a6d63679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170134a6d63679&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2556832853","title":"每日卖空追踪 | 来凯医药-B 08月04日卖空量成交4.6万股，卖空比例为2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556832853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556832853?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 16:30","pubTimestamp":1754296226,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间08月04日，涨4.79%，卖空量成交4.6万股%，较上一交易日减少25.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804171949a4741f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804171949a4741f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2556780840","title":"来凯医药-B盘中异动 下午盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556780840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556780840?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 14:19","pubTimestamp":1754288342,"startTime":"0","endTime":"0","summary":"2025年08月04日下午盘14时19分，来凯医药-B股票出现波动，股价大幅上涨5.02%。截至发稿，该股报18.400港元/股，成交量152.65万股，换手率0.37%，振幅8.45%。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，中生北控生物科技、创胜集团-B、云顶新耀涨幅较大，振幅较大的相关个股有云康集团、奥星生命科技、药明巨诺-B，振幅分别为12.75%、12.24%、11.55%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080414190294ce0de1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080414190294ce0de1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2556871162","title":"中金：首予来凯医药-B(02105)跑赢行业评级 目标价27.02港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556871162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556871162?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 10:23","pubTimestamp":1754274235,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，首次覆盖来凯医药-B给予跑赢行业评级，目标价27.02港元，基于DCF估值法，较当前股价有43.7%的上行空间。市场认为礼来Bimagrumab的数据强势，该行认为其已经揭示了ActRII靶点减脂增肌的成药潜力，公司LAE102则有望在选择性、给药便利、安全性等方面做出差异化优势，该行看好该管线国际化临床和商业价值解锁的潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105"],"gpt_icon":0},{"id":"2556841968","title":"这款中国创新药管线，诺和诺德最应该BD","url":"https://stock-news.laohu8.com/highlight/detail?id=2556841968","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556841968?lang=zh_cn&edition=fundamental","pubTime":"2025-08-02 07:31","pubTimestamp":1754091096,"startTime":"0","endTime":"0","summary":"如果把时间线拉长，在最近一年多的时间内，诺和诺德的股价距离最高点已经跌去了三分之二，4000多亿美元的市值直接蒸发。如何弯道超车，是诺和诺德必须面临的一个课题。2025年6月，在美国糖尿病协会的年度会议上，礼来公布了其增肌药物Bimagrumab联合诺和诺德减重药司美格鲁肽的最新临床数据。很显然，诺和诺德在这个赛道，又一次落后了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802073647a4707547&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802073647a4707547&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868836757.USD","02105","LU0289739699.SGD","LU2417539215.USD","LU0097036916.USD","SG9999014906.USD","BK4599","LU0823416689.USD","SGXZ31699556.SGD","LU2456880835.USD","LU2360106947.USD","LU2089984988.USD","LU0058720904.USD","LU0820561818.USD","LU2237443382.USD","LU2108987350.USD","LU1291159041.SGD","LU2462157665.USD","LU1712237335.SGD","SG9999014914.USD","LU1023059063.AUD","IE00BK4W5L77.USD","LU2112291526.USD","LU2746668461.USD","LU1804176565.USD","LU0786609619.USD","LU0122379950.USD","LLY","LU0079474960.USD","LU0256863811.USD","LU2491050154.USD","LU0203202063.USD","IE00BJLML261.HKD","IE00B4R5TH58.HKD","LU1720051108.HKD","LU2265009873.SGD","SG9999001176.USD","LU0320765059.SGD","LU1548497426.USD","LU1814569148.SGD","IE0009355771.USD","LU0316494557.USD","LU2491049909.HKD","LU1280957306.USD","NVO","LU1988902786.USD","LU0006306889.USD","LU0385154629.USD","IE00B2B36J28.USD","LU0943347566.SGD","IE0002141913.USD"],"gpt_icon":1},{"id":"2556891582","title":"每日卖空追踪 | 来凯医药-B 08月01日卖空量成交9500股，卖空比例为0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556891582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556891582?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 16:30","pubTimestamp":1754037029,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间08月01日，跌6.81%，卖空量成交9500股%，较上一交易日减少48.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801171938a46f6e33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801171938a46f6e33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2556865815","title":"来凯医药-B盘中异动 早盘股价大跌5.32%报17.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556865815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556865815?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 10:56","pubTimestamp":1754017004,"startTime":"0","endTime":"0","summary":"2025年08月01日早盘10时56分，来凯医药-B股票出现异动，股价大幅下挫5.32%。截至发稿，该股报17.800港元/股，成交量83.85万股，换手率0.21%，振幅6.91%。资金方面，该股资金流入606.951万港元，流出799.511万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.04%。该信息摘要如下：来凯医药-B宣布，董事会会议将于2025年8月13日（星期三）举行，旨在考虑及批准公司及其附属公司截至2025年6月30日止六个月的中期业绩及其刊发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801105644a46ec025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801105644a46ec025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2556207890","title":"来凯医药-B：减脂增肌赛道新锐 全球化创新布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2556207890","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556207890?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 00:00","pubTimestamp":1753977600,"startTime":"0","endTime":"0","summary":"公司是一家全球化的生物医药科技公司，深耕代谢、肿瘤等疾病领域，是国内减脂增肌赛道的新锐。根据弗若斯特沙利文测算，2024 年GLP-1RA 市场规模达147 亿美元，占全球肥胖超重药物市场的86.6%，其预计到 2034 年这一占比将提升至 93.9%，其市场规模将达到541 亿美元。研究结果显示，使用GLP-1RA 减肥的患者中，所减体重里瘦体重的占比或高达40%以上，引发对肌肉流失的担忧。公司是国内减脂增肌赛道先行者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801190426a46f9f28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801190426a46f9f28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2555070823","title":"来凯医药-B(02105.HK)：LAE103的新药临床试验已获得美国食品药品监督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2555070823","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555070823?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 12:27","pubTimestamp":1753936072,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03347","02105","BK1576","BK1583","BK1141","BK1161"],"gpt_icon":0},{"id":"2555077764","title":"来凯医药-B：LAE103的新药临床试验(IND)已获得美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2555077764","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555077764?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 12:06","pubTimestamp":1753934760,"startTime":"0","endTime":"0","summary":"格隆汇7月31日丨来凯医药-B(02105.HK)宣布，LAE103的IND已获美国FDA批准。公司致力于为需要新型治疗方案的代谢疾病患者提供这种精准治疗。LAE103(一种针对Act RIIB的单克隆抗体)为公司自主研发、潜在用于治疗肌少性肥胖症及其他肌肉相关疾病。LAE103是一款Act RIIB选择性抗体。集团正积极推动该候选药物进入临床研究阶段，旨在为肌少性肥胖症及其他肌肉相关疾病提供创新疗法。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731120856a6cacb59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731120856a6cacb59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1161","03347","02105","BK1583","BK1576"],"gpt_icon":0},{"id":"2555044471","title":"每日卖空追踪 | 来凯医药-B 07月30日卖空量成交1000股，卖空比例为0.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555044471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555044471?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 16:30","pubTimestamp":1753864230,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月30日，跌4.1%，卖空量成交1000股%，较上一交易日减少90.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172102a6c970c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172102a6c970c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2555103658","title":"来凯医药-B拟8月13日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2555103658","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555103658?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 16:38","pubTimestamp":1753778309,"startTime":"0","endTime":"0","summary":"格隆汇7月29日丨来凯医药-B(02105.HK)宣布，董事会会议将于2025年8月13日（星期三）举行，旨在（其中包括）考虑及批准公司及其附属公司截至2025年6月30日止六个月的中期业绩及其刊发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291638449725054f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291638449725054f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2555032377","title":"来凯医药-B07月29日获主力加仓1600.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555032377","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555032377?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 16:16","pubTimestamp":1753776966,"startTime":"0","endTime":"0","summary":"07月29日, 来凯医药-B股价涨3.20%，报收19.98元，成交金额8423.6万元，换手率1.05%，振幅7.13%，量比1.44。来凯医药-B今日主力资金净流入1600.4万元，连续3日净流入，上一交易日主力净流入581.4万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为57.14%，平均涨幅为5.75%。该股近5个交易日上涨7.77%，主力资金累计净流入2146.6万元；近20日主力资金累计净流入3746.0万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729170511a4695738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729170511a4695738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":195,"code":"91000000","status":"200"}]}}